RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ELIA E
Collezione AOU Novara

Items : 6

Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry. in American journal of cardiovascular drugs : drugs, devices, and other interventions / Am J Cardiovasc Drugs. 2023 Jan;23(1):77-87. doi: 10.1007/s40256-022-00554-5. Epub 2022 Oct 31.

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

De Ferrari GM; Dominguez-Rodriguez A; Conrotto F; D'Ascenzo F; Kawashiri MA; Nie SP; Kawaji T; Quadri G; Huczek Z; Paz RC; Juanatey JRG; Nuñez-Gil I; Song X; Cerrato E; Rognoni A; Correia L; Xanthopoulou I; Velicki L; Wilton SB; Henriques JPS; Templin C; Iannaccone M; Liebetrau C; Manzano-Fernández S; Kinnaird T; Ariza-Solé A; Abu-Assi E; Wa?ha W; Raposeiras-Roubin S; et alii...

Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study. in European heart journal. Quality of care & clinical outcomes / Eur Heart J Qual Care Clin Outcomes. 2022 Nov 17;8(8):881-891. doi: 10.1093/ehjqcco/qcac002.

2022
AOU Città della Salute di Torino
AOU Novara

Dominguez-Rodriguez A; Elia E; Wa?ha W; Henriques JPS; Piroli F; Conrotto F; Kinnaird T; Cerrato E; Omedè P; Gallone G; Manzano-Fernández S; Liebetrau C; Chieffo A; Iannaccone M; Leonardi S; Bruno F; De Filippo O; D'Ascenzo F; Patti G; Raposeiras-Roubin S; Abu-Assi E; De Ferrari GM;

Facial dermatoses and use of protective mask during Covid-19 pandemic: A clinical and psychological evaluation in patients affected by moderate-severe atopic dermatitis under treatment with dupilumab. in Dermatologic therapy / Dermatol Ther. 2022 Jul;35(7):e15573. doi: 10.1111/dth.15573. Epub 2022 May 22.

2022
AOU Novara

Vanessa M; Elia E; Federica V; Edoardo C; Chiara A; Francesca G; Paola S;

Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico / Clin Transl Oncol. 2020 Sep;22(9):1603-1610. doi: 10.1007/s12094-020-02305-x. Epub 2020 Feb 11.

2020
AOU Novara

Coco S; Spallarossa P; Alama A; Tagliamento M; Biello F; Rossi G; Dal Bello MG; Rijavec E; Ferrara D; Ansaldo AM; Elia E; Bardi N; Minetti S; Vecchié A; Carbone F; Grossi F; Bonaventura A; Dallegri F; Genova C; Montecucco F;

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer. in Clinical & experimental metastasis / Clin Exp Metastasis. 2019 Oct;36(5):449-456. doi: 10.1007/s10585-019-09984-z. Epub 2019 Aug 2.

2019
AOU Novara

Genova C; Dallegri F; Coco S; Spallarossa P; Biello F; Rossi G; Alama A; Tagliamento M; Dal Bello MG; Rijavec E; Ferrara D; Ansaldo AM; Elia E; Bardi N; Minetti S; Vecchié A; Bonaventura A; Grossi F; Carbone F; Montecucco F;

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2019 Aug;68(8):1351-1358. doi: 10.1007/s00262-019-02367-z. Epub 2019 Jul

2019
AOU Novara

Dallegri F; Coco S; Spallarossa P; Alama A; Tagliamento M; Biello F; Rossi G; Dal Bello MG; Rijavec E; Ferrara D; Ansaldo AM; Elia E; Bardi N; Minetti S; Vecchié A; Carbone F; Grossi F; Bonaventura A; Genova C; Montecucco F;